DEF: Enveric Biosciences Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing

Enveric Biosciences is asking shareholders to approve a reverse stock split to increase its share price and maintain its listing on the Nasdaq Capital Market.

Summary

• Enveric Biosciences is holding a special meeting on January 17, 2025, to seek stockholder approval for a reverse stock split.
• The proposed reverse stock split would combine shares at a ratio between 1-for-10 and 1-for-100, with the exact ratio to be determined by the Board of Directors.
• The primary goal of the reverse stock split is to increase the company's stock price to meet Nasdaq's minimum bid price requirement of $1.00 per share.
• The company received a delisting notice from Nasdaq on November 20, 2024, after failing to maintain the minimum bid price.
• The company has appealed the delisting notice, which has temporarily stayed the delisting process.
• The reverse stock split will reduce the number of outstanding shares but will not change the total authorized shares or the par value of the stock.
• The board has the discretion to implement the reverse stock split or abandon it, even if approved by stockholders.
• The company has hired Kingsdale Advisors to assist in soliciting proxies for a fee of $10,600 plus expenses.

Sentiment

Score: 5

Explanation: The document is neutral in tone, focusing on the procedural aspects of the reverse stock split and the need to maintain Nasdaq listing. While the situation is challenging, the company is taking a standard approach to address it.

Positives

• The reverse stock split aims to increase the stock price, potentially making it more attractive to a broader range of investors.
• A higher stock price could encourage increased investor interest and promote greater liquidity.
• The reverse stock split could allow a broader range of institutions to invest in the company's stock.
• The company believes the reverse stock split will provide the Board flexibility to make the stock a more attractive investment for institutional investors.
• The reverse stock split could increase interest from analysts and brokers who may have policies against following companies with low stock prices.

Negatives

• The reverse stock split may not increase the stock price over the long term.
• The reverse stock split could decrease the liquidity of the stock due to a reduced number of outstanding shares.
• Some stockholders may end up with odd lots of shares, which can be more difficult to sell.
• The reverse stock split could lead to a decrease in the company's overall market capitalization if the price does not increase proportionally.
• If the reverse stock split is not approved, the company could be delisted from Nasdaq.

Risks

• The reverse stock split may not increase the stock price as intended.
• The reverse stock split could decrease the liquidity of the stock.
• Stockholders may end up with odd lots of shares, which can be more difficult to sell.
• The reverse stock split could lead to a decrease in the company's overall market capitalization.
• There is no guarantee that the company will regain compliance with Nasdaq listing requirements even if the reverse stock split is implemented.
• If the reverse stock split is not approved, the company could be delisted from Nasdaq.

Future Outlook

The company aims to increase its stock price to meet Nasdaq's minimum bid price requirement and maintain its listing on the Nasdaq Capital Market. The board will determine the specific ratio of the reverse stock split and whether to implement it based on market conditions and the company's best interests.

Management Comments

• The Board has determined that Reverse Stock Split Proposal is in the best interest of the Company and its stockholders and has approved the proposal.
• On behalf of the board of directors, I urge you to submit your vote as soon as possible, even if you currently plan to attend the Special Meeting online.
• We believe that the Reverse Stock Split is our best option to meet the criteria to satisfy the Minimum Bid Price Requirement for continued listing on The Nasdaq Capital Market.

Industry Context

This announcement is related to the company's need to maintain its listing on the Nasdaq Capital Market, which is a common challenge for companies with low stock prices. Reverse stock splits are a common mechanism used by companies to increase their stock price and avoid delisting.

Comparison to Industry Standards

• Many companies facing delisting from Nasdaq or other exchanges have used reverse stock splits to increase their share price.
• For example, companies like Aeterna Zentaris and Biocept have recently implemented reverse stock splits to regain compliance with listing requirements.
• The specific ratio of the reverse stock split (between 1-for-10 and 1-for-100) is within the typical range seen in similar situations.
• The company's situation is similar to other biotech companies that have experienced stock price declines and are seeking to maintain their listing status.

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split, potentially seeing a reduction in the number of shares they own.
• The reverse stock split aims to increase the stock price, which could benefit shareholders if successful.
• The company's employees may be affected by the potential delisting if the reverse stock split is not approved.
• The company's creditors may be impacted by the company's ability to maintain its listing and access to capital.

Next Steps

• Stockholders will vote on the reverse stock split proposal at the special meeting on January 17, 2025.
• The board will determine the specific ratio of the reverse stock split if approved by stockholders.
• The company will file the reverse stock split charter amendment with the Secretary of State of Delaware if the board decides to implement it.
• The company will announce the reverse stock split ratio publicly if the board decides to implement it.

Key Dates

Keywords

reverse stock split, Nasdaq, delisting, minimum bid price, stock price, proxy, shareholders, compliance